Pathfinder Cell Therapy, Inc.

Q: Sep 30 2015

Q: Jun 30 2015

Q: Mar 31 2015

FY: Dec 31 2014

Q: Sep 30 2014

Q: Jun 30 2014

FY: Dec 31 2012

Q: Mar 31 2014

FY: Dec 31 2013

FY: Dec 31 2012

FY: Dec 31 2013

Q: Sep 30 2013

Q: Jun 30 2013

Q: Mar 31 2013

FY: Dec 31 2012

FY: Dec 31 2012

Q: Sep 30 2012

Q: Jun 30 2012

Q: Mar 31 2012

FY: Dec 31 2011

8.01

2.03,3.02

2.03,3.02

2.03,3.02

2.03,3.02

2.03,3.02

2.03,3.02

2.03,3.02

2.03,3.02

2.03,3.02

2.03,3.02

2.03,3.02

2.03,3.02

2.03,3.02

2.03,3.02

2.03,3.02

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Certification of termination of registration of a class of securities (Section 12(g))

Notice of Effectiveness

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Post Effective Amendment to S-8

Notice of Effectiveness

Notice of Effectiveness

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Notice of Effectiveness

Post-effective amendment to a registration statement

Post Effective Amendment to S-8

No description available

No description available

No description available

No description available

No description available

No description available

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Breisgau Bio Ventures S.A.

Gruber Joerg

Breisgau Bio Ventures S.A.

Gruber Joerg

Breisgau Bio Ventures S.A.

FRANKLIN RICHARD L

Gruber Joerg

FRANKLIN RICHARD L

Gruber Joerg

Breisgau Bio Ventures S.A.

FRANKLIN RICHARD L

FRANKLIN RICHARD L

Gruber Joerg

FRANKLIN RICHARD L

Gruber Joerg

Chu Zen

Brooks John L

Benson John

Benson John

Reeve Brock C.

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

No description available